Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 38.20
+0.92 (2.47%)
Aug 14, 2026, 5:29 PM CET
STO:SUS Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 977.14 | 992.34 | 884.09 | 882.85 | 802.54 | 366.78 |
Revenue Growth | 3.23% | 12.25% | 0.14% | 10.01% | 118.81% | 249.98% |
Gross Profit Gross Profit Growth | 640.05 | 657.68 | 597.9 | 612.88 | 531.52 | 265.94 |
Operating Income Operating Income Growth | 111.72 | 131.58 | 144.22 | 189.15 | 156.86 | 82.98 |
Net Income Net Income Growth | 52.21 | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 |
Earnings Per Share EPS Growth | 1.02 | 1.31 | 2.58 | 4.59 | 3.69 | 2.02 |
EPS Growth | -62.93% | -49.24% | -43.79% | 24.39% | 82.67% | 348.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Educational Products Educational Products Growth | 508.58 | 501.54 | 442.5 | 518.43 | 507.95 | 197.41 |
Industry/OEM Industry/OEM Growth | 468.56 | 490.8 | 441.59 | 364.42 | 294.59 | 169.37 |
Total Total Growth | 977.14 | 992.34 | 884.09 | 882.85 | 802.54 | 366.78 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 667.73 | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 |
Total Debt Total Debt Growth | 2.15 | 56.4 | 56.94 | 40.02 | 14.68 | 12.07 |
Net Cash (Debt) Net Cash Growth | 665.58 | 560.03 | 911.22 | 594.34 | 419.05 | 304.61 |
Net Cash Growth | 8.89% | -38.54% | 53.31% | 41.83% | 37.57% | 259.05% |
Net Cash Per Share Net Cash Per Share Growth | 13.04 | 10.98 | 17.86 | 11.67 | 8.23 | 7.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 150.06 | 79.8 | 137.23 | 238.29 | 129.49 | 39.08 |
Capital Expenditures CapEx Growth | -18.88 | -11.68 | -6.1 | -10.46 | -9.35 | -3.87 |
Free Cash Flow Free Cash Flow Growth | 131.18 | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 |
Free Cash Flow Growth | 35.37% | -48.05% | -42.45% | 89.65% | 241.18% | 54.26% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.50% | 66.27% | 67.63% | 69.42% | 66.23% | 72.51% |
Operating Margin | 11.43% | 13.26% | 16.31% | 21.43% | 19.55% | 22.62% |
Pretax Margin | 7.73% | 10.09% | 17.88% | 30.39% | 25.94% | 17.94% |
Profit Margin | 5.34% | 6.73% | 14.89% | 26.50% | 23.42% | 23.52% |
FCF Margin | 13.43% | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.33 | 24.82 | 60.43 | 39.80 | 44.51 | 165.81 |
Forward PE | 15.28 | 14.63 | 34.77 | 40.02 | 54.94 | 157.93 |
P/FCF Ratio | 14.86 | 24.35 | 60.67 | 40.87 | 69.65 | 406.13 |
PS Ratio | 1.99 | 1.67 | 9.00 | 10.55 | 10.43 | 38.99 |